Clinical Trial Update: Phase 2 Study in Adults Sensitized to Short Ragweed [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a treatment for allergic rhinitis in adults sensitized to short ragweed has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Snippet

Sponsor: Antigen Laboratories, Inc. | Conditions: Allergic Rhinitis | Phase 2 | Status: WITHDRAWN